Researchers established baseline thymosin beta-4 levels in racehorses and developed a method to detect synthetic TB4 doping through non-natural synthesis impurities in plasma.
Single-dose detection achievedNon-natural synthesis impurities from commercial TB4 products were detectable in horse plasma after just one administration, providing a practical doping detection method.
What the researchers found
The study established the first population reference range for endogenous TB4 concentration in racehorse blood. TB4 levels were not significantly affected by gender, age, or horse breed. A critical pre-analytical finding was that TB4 concentrations increase significantly and rapidly in plasma stored at 4°C without cell separation, due to cell lysis releasing intracellular TB4.
Most significantly, the researchers demonstrated that administration of a commercially available TB4 product to a horse resulted in detectable non-natural synthesis impurities in equine plasma, providing a reliable marker for doping detection.
Why it matters
TB4 is one of the most commonly discussed peptides in performance enhancement circles, marketed online for tissue repair and regeneration. This study is significant because it provides anti-doping laboratories with both baseline reference values and a concrete detection method. The finding that synthetic impurities can be detected from a single dose makes doping controls for this peptide practically feasible for the first time.
How the study worked
Population study measuring endogenous TB4 concentrations in blood samples from racing horses across different genders, ages, and breeds. Pre-analytical stability experiments tested the effect of delayed plasma separation on TB4 concentrations. An administration study gave a single dose of a commercial TB4-containing product to a horse and tested plasma for non-natural synthesis impurities as a doping detection strategy.
What this study cannot tell us
The administration study used a single horse with a single dose, limiting the generalizability of the impurity detection findings. The study focuses on equine physiology and may not directly translate to human TB4 reference ranges. The specific synthesis impurity detected is not named, and different manufacturers may produce products with different impurity profiles. Long-term detection windows after administration are not reported.
How to read the evidence
This is an analytical chemistry and population study with a single-animal administration experiment. The population data is useful for reference range establishment, but the detection proof-of-concept relies on a single administration case.
When this study was published
Published in 2025, this is current research addressing the growing challenge of peptide doping detection in an era of widespread online availability of synthetic peptides.
The bigger picture
Thymosin beta-4 sits at the intersection of peptide science and anti-doping regulation. While TB4 is one of the most abundant natural peptides in mammalian cells, synthetic versions are widely sold online for their purported healing and performance-enhancing properties. This research extends beyond horse racing — the detection methodology using synthesis impurities could be adapted for human anti-doping testing, and the pre-analytical stability findings are relevant for any clinical or research use of TB4 measurements.
Questions still open
- How long after TB4 administration can the synthesis impurities be detected in plasma?
- Could this impurity-based detection approach be adapted for human anti-doping testing?
- Do different commercial TB4 products produce the same or different detectable impurities?
Common questions
What is thymosin beta-4 and why would it be used in horse racing?
How can labs tell the difference between natural and synthetic TB4?
Read the original research
Equine Doping Controls of Thymosin β 4: A Population Study and Strategy for Misuse Detection.
Drug testing and analysis, 17(7), 1071-1077
Citation
Delcourt, Vivian; Garcia, Patrice; Chabot, Benjamin; Aber, Nina; Pescher, Mylène; Cacault, Marie; Scholtes, Priscilla; Loup, Benoit; Barnabé, Agnès; Popot, Marie-Agnès; Bailly-Chouriberry, Ludovic. (2025). Equine Doping Controls of Thymosin β 4: A Population Study and Strategy for Misuse Detection.. Drug testing and analysis, 17(7), 1071-1077. https://doi.org/10.1002/dta.3806